Atara Biotherapeutics Inc (ATRA) stock news · rev $120.8M
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
This ATRA news page leads with what Atara Biotherapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for ATRA yet. We will not pad this page with generic market recap.
Latest reported ATRA revenue for 2025-12-31 was $120.8M. Net income was $32.7M. Revenue was down 6.3% from 2024-12-31 to 2025-12-31. ATRA currently screens at market cap $87.1M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ATRA stock page; for the tape open the quote page.
ATRA stock news FAQ
What are ATRA's latest revenue and net income?
Latest cached Atara Biotherapeutics Inc (ATRA) revenue for Dec 31, 2025 was $120.8M. Net income was $32.7M. Statements: https://lician.com/financials/atra
How did ATRA revenue change from the prior cached period?
Cached Atara Biotherapeutics Inc (ATRA) revenue was down 6.3% from $128.9M (Dec 31, 2024) to $120.8M (Dec 31, 2025). Statements: https://lician.com/financials/atra
What is ATRA's market cap?
Atara Biotherapeutics Inc (ATRA) market cap is $87.1M on the latest cached fundamentals snapshot.
What kind of company is ATRA?
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Where is ATRA stock news listed?
Cached stock news for Atara Biotherapeutics Inc (ATRA) is listed at https://lician.com/news/atra. Filings: https://lician.com/sec/atra
Not investment advice.